Pfizer (PFE) is to develop weight-loss drugs, WSJ reports
Pfizer's move to develop weight-loss drugs signals a strategic pivot that could tap into the growing demand in the obesity treatment space.
Arista Networks Inc. (ANET) Q1 2026 (USD): Adj. EPS 0.87 (exp. 0.81), Revenue 2.709bln (exp. 2.62bln), Q2 adj. EPS view 0.88 (exp. 0.86), revenue view 2.8bln (exp. 2.78bln).
Lumentum Holdings (LITE) Q3 2026 (USD): EPS 2.37 (exp. 2.27), Revenue 808mln (exp. 810mln)
Pfizer (PFE) is to develop weight-loss drugs, WSJ reports
UKMTO says it has received a report of an incident within the Strait of Hormuz and verified source reported a cargo vessel hit by unknown projectile
Amazon (AMZN) announces plans to invest more than EUR 15bln in France, creating more than 7,000 permanent jobs
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This initiative may enhance their product portfolio, potentially driving future revenue growth, and could recalibrate market perceptions of Pfizer's capabilities beyond traditional pharmaceuticals. Stakeholder sentiment will likely hinge on the drug development's success and timelines, influencing their equity valuation and competitive positioning in the market.
Related headlines
- Merck (MRK) veteran and psychedelics developer tapped for top FDA job8 hours ago
- US EQUITY OPEN: US indices open in the red amid downbeat risk tone after Labor Day holiday14 hours ago
- US PREMARKET MOVERS: NVS, TSLA, UNFI, UBER, INTC, RGTI, AMGN, PTON15 hours ago
- Bristol Myers Squibb (BMY) said a trial met its primary endpoint of overall response rate and key secondary endpoint of complete response rate in a heavily pretreated patient population exposed to a prior BCMA-targeted therapy17 hours ago
- US Market Wrap: Stocks fall and crude gains amid escalating geopolitics 8 hours ago
- Newsquawk European Market Wrap - 8th September 202614 hours ago
- Santander (SAN SM) files to sell USD-denominated 3-parter16 hours ago
- AstraZeneca (AZN LN) says Phase III tozorakimab data in COPD showed a 29%-34% reduction in exacerbations16 hours ago
- US BROKER MOVES: INTC upgraded at Northland; PTON downgraded at MS16 hours ago
- US Department of Justice plans closer scrutiny of Fox's (FOXA) USD 22bln Roku (ROKU) deal, according to Semafor5 hours ago
- Broadcom (AVGO) CEO says co. can lock in chip supply for 2027 and it is in the process of locking in 2028 supply 8 hours ago
- OpenAI is launching ChatGPT Images 2.5 on Tuesday, Axios reports10 hours ago
- OpenAI CFO says enterprise business has been "on a tear", CNBC reports11 hours ago
- FDA notes FI recalls dog supplements due to possible salmonella contamination11 hours ago
- Google (GOOGL) says Gemini is seeing strong adoption across both large enterprises and small and medium-sized businesses, supporting broader commercial traction for Alphabet's AI platform11 hours ago
- Pentagon has decided on the maker of the US navy's next-generation stealth fighter, according to reports; US navy next-generation stealth fighter manufacturer announcement to come within weeks11 hours ago
- Newsquawk Daily US Earnings Estimates: 9th September 2026 - COO12 hours ago
- Qualcomm (QCOM) announces a multi-generational pact with Amazon (AMZN) to build next-gen AI data centre infrastructure15 hours ago
- Corning (GLW) has entered into a fibre deal with Verizon (VZ) for the building of AI connectivity, CNBC reports15 hours ago
- Google Cloud (GOOGL) and Accenture (ACN) launch unit to put AI engineers on-site with customers, reports WSJ16 hours ago
The whole workspace, free to try.
Try it free